Clinical Trials Logo

Locally Advanced or clinical trials

View clinical trials related to Locally Advanced or.

Filter by:
  • None
  • Page 1

NCT ID: NCT02447328 Completed - Clinical trials for Metastatic Breast Cancer

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Start date: May 29, 2015
Phase: Phase 4
Study type: Interventional

This single-arm study aims to assess the safety and tolerability profile of Fulvestrant(Faslodex®) as 2nd line and later therapy in postmenopausal women with locally advanced or metastatic breast cancer. The primary objective is to evaluate the adverse events after Fulvestrant (Faslodex®) for about 6 months